In summary, our studies demonstrate that recombinant SARS-CoV-2 spike S1 causes death of human NSCLC cells via its interaction with ACE2 and that intranasal administration of recombinant spike S1 leads to regression of cancer in vivo in the lung of NNK-intoxicated mouse model. Here, ACE2 is linked to non-small cell lung carcinoma.